WallStreetZenWallStreetZen

NASDAQ: TCRT
Alaunos Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TCRT stock forecasts and price targets.

Forecast return on equity

Is TCRT forecast to generate an efficient return?
Company
N/A
Industry
72.03%
Market
80.59%

Forecast return on assets

Is TCRT forecast to generate an efficient return on assets?
Company
N/A
Industry
30.89%

TCRT revenue growth forecast

How is TCRT forecast to perform vs Biotechnology companies and vs the US market?
Company
3,432.34%
Industry
65.11%
Market
11.3%
TCRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TCRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TCRT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TCRT$0.62N/AN/A
PIRS$7.40N/AN/A
ABVC$0.93N/AN/A
ELAB$0.52N/AN/A
BNOX$0.84$8.00+853.52%Buy

Alaunos Therapeutics Stock Forecast FAQ

What is TCRT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TCRT) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.

What is TCRT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TCRT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 30.89%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.